Alzheimer’s disease serves as bookends to Brent Vaughan’s career so far. Twenty years ago, he worked for a Bay Area biotech whose pipeline included small molecules in development for the ...
Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment for the ...
NEW YORK--(BUSINESS WIRE)--Cognito, an international financial services communications and marketing agency, today announced the appointment of new senior leadership to its financial communications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback